Response to Karp-Tatham et al.
Astrid Marchal, Vanessa Sancho-Shimizu, Laurent Abel, Jean-Laurent Casanova, Aurélie Cobat, Alexandre Bolze
{"title":"Response to Karp-Tatham et al.","authors":"Astrid Marchal, Vanessa Sancho-Shimizu, Laurent Abel, Jean-Laurent Casanova, Aurélie Cobat, Alexandre Bolze","doi":"10.1016/j.xhgg.2025.100407","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":34530,"journal":{"name":"HGG Advances","volume":" ","pages":"100407"},"PeriodicalIF":3.3000,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HGG Advances","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.xhgg.2025.100407","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
对致编辑的信的回应：经典HLA基因与无症状SARS-CoV-2感染之间缺乏关联。
这封信强调了在原发性SARS-CoV-2感染急性期未接种疫苗的个体中研究HLA等位基因与在接种疫苗的个体中研究任何SARS-CoV-2感染（包括再感染、突破性感染和原发性感染）之间的关键区别。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
